Clene Inc. (CLNN)

↓ Download CSV

CIK 0001822791 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Clene Inc. reported revenue of $200.0K, down 41.5% from the prior year. The company ran a net loss, with a net margin of -13086.5%. It held $18.13M in total assets against $35.72M in total liabilities.

Key ratios (FY2025)

-11541.5%
Operating margin
-13086.5%
Net margin
-41.5%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$200.0K$342.0K$654.0K$473.0K$723.0K$206.0K
Cost of Revenue$43.0K$70.0K$121.0K$26.0K$289.0K
Operating Income-$23.08M-$33.09M-$40.54M-$48.41M-$49.98M-$20.21M-$16.33M
Net Income-$26.17M-$39.40M-$49.50M-$29.92M-$9.74M-$19.28M-$16.16M
EPS (Diluted)$-2.65$-5.67$-9.43$-0.46$-0.16
Total Assets$18.13M$27.34M$52.34M$44.49M$63.06M$68.24M$14.88M
Total Liabilities$35.72M$36.19M$38.95M$41.26M$50.47M$67.90M$9.99M
Shareholders' Equity-$17.59M-$8.86M$13.39M$3.24M$12.60M$341.0K-$67.77M-$52.04M
Cash & Equivalents$5.19M$12.15M$28.82M$18.33M$50.29M$59.27M$8.79M
Operating Cash Flow-$18.55M-$21.33M-$30.17M-$39.01M-$34.62M-$18.93M-$13.20M
Capital Expenditures$39.0K$15.0K$330.0K$5.18M$1.33M$387.0K$294.0K
Shares Outstanding10.85M8.09M6.42M74.76M62.31M59.53M17.36M